Nebenwirkungen · Emadine
EMADINE 0.5 mg/ml eye drops, solution, single-dose container. · Abschnitt 4.8 · PDF-Seite 9
HOS-089528 · Präparat HOS-083863
In 13 clinical studies involving 696 patients, Emadine was administered one to four times daily in both eyes for up to 42 days. In clinical trials, approximately 7% of patients experienced an adverse drug reaction associated with the use of Emadine; however, less than 1% of these patients discontinued therapy due to these adverse drug reactions. No serious ophthalmic or systemic adverse drug reactions were reported in the clinical trials. The most common adverse drug reactions were eye pain and eye pruritus, occurring in 1% to of 2.0% of patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-01T09:23:00Z · SHA-256 a84dd86b87f52b26d663e845ac443cf8a7152e4cd0405bc00756e653d43a0eb2 · Passage 5b2f04a03fd508d57bc284602c6b90fa5d2677bf07f4fff3b75acc33f2d7d7a8 · Zeichen 27–580 im Abschnitt